Appointment of Chief Medical Officer at Moberg Pharma
STOCKHOLM, July 30[th], 2020, Moberg Pharma AB (OMX: MOB) announces the appointment of Dr Cindy Wong as Chief Medical Officer of Moberg Pharma. Dr Wong will during the fall be joining the management team at Moberg Pharma coming from a previous position as Vice President and Head of Global Clinical Development at Metz Pharmaceuticals GmbH.Moberg Pharma is pleased to announce the appointment of Dr Cindy Wong as Chief Medical Officer. Dr Wong brings extensive international experience in clinical development and registration of new products in a number of treatment areas including Dermatology.